A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.

about

A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.

Item

http://www.wikidata.org/entity/Q38743426

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Novel Compound ARN-3236 Inhi ...... and Xenografts to Paclitaxel.

@en

type

Item

label

A Novel Compound ARN-3236 Inhi ...... and Xenografts to Paclitaxel.

@en

prefLabel

A Novel Compound ARN-3236 Inhi ...... and Xenografts to Paclitaxel.

@en

P1476

A Novel Compound ARN-3236 Inhi ...... s and Xenografts to Paclitaxel

@en

P2093

Abdulkhaliq Alsaadi

http://www.w3.org/2001/XMLSchema#string

Ahmed A Ahmed

http://www.w3.org/2001/XMLSchema#string

Albandri Alfraidi

http://www.w3.org/2001/XMLSchema#string

Hailing Yang

http://www.w3.org/2001/XMLSchema#string

Hariprasad Vankayalapati

http://www.w3.org/2001/XMLSchema#string

Hiroshi Takemori

http://www.w3.org/2001/XMLSchema#string

Janice M Santiago-O'Farrill

http://www.w3.org/2001/XMLSchema#string

Jinhua Zhou

http://www.w3.org/2001/XMLSchema#string

Jinsong Liu

http://www.w3.org/2001/XMLSchema#string

Venkata Krishna Yerramreddy Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer

The mechanism regulating the dissociation of the centrosomal protein C-Nap1 from mitotic spindle poles

Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin

The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector

Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche

Drug combination studies and their synergy quantification using the Chou-Talalay method

Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.

P304

1945-1954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-16-1562

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert C. Bast

Shu Zhang

Zhen Lu

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27678456

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5436602

http://www.w3.org/2001/XMLSchema#string